These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35750531)

  • 1. Tranexamic acid for treatment of symptomatic hemorrhagic conversion following administration of tenecteplase for acute ischemic stroke.
    Hailu K; Ragoonanan D; Davis H
    Am J Emerg Med; 2022 Sep; 59():216.e1-216.e5. PubMed ID: 35750531
    [No Abstract]   [Full Text] [Related]  

  • 2. Tenecteplase for acute ischaemic stroke.
    Sandset EC; Tsivgoulis G
    Lancet; 2022 Jul; 400(10347):138-139. PubMed ID: 35779556
    [No Abstract]   [Full Text] [Related]  

  • 3. Tenecteplase versus alteplase for early treatment of ischaemic stroke - Authors' reply.
    Churilov L; Bivard A; Parsons MW
    Lancet Neurol; 2022 Nov; 21(11):959. PubMed ID: 36270302
    [No Abstract]   [Full Text] [Related]  

  • 4. Tranexamic acid for treatment of tenecteplase related hemorrhagic conversion.
    Lin YT; Ho MP
    Am J Emerg Med; 2022 Nov; 61():229. PubMed ID: 35902327
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous tenecteplase compared with alteplase for acute ischemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial.
    Ferguson E; Yadav K
    CJEM; 2023 Feb; 25(2):121-122. PubMed ID: 36577932
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute Treatment of Ischemic Stroke.
    Lyden S; Wold J
    Neurol Clin; 2022 Feb; 40(1):17-32. PubMed ID: 34798968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials.
    Coutts SB; Berge E; Campbell BC; Muir KW; Parsons MW
    Int J Stroke; 2018 Dec; 13(9):885-892. PubMed ID: 30035698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IV tenecteplase: A non-inferior alternative to alteplase?
    Zubair AS; Sheth KN
    Med; 2022 Aug; 3(8):519-520. PubMed ID: 35963230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In acute ischemic stroke, early IV tenecteplase was noninferior to alteplase for excellent functional outcome.
    Ferguson E; Lang E
    Ann Intern Med; 2022 Nov; 175(11):JC124. PubMed ID: 36315948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenecteplase for acute stroke: the thrombolysis puzzle.
    Coutts SB; Yu AYX
    Lancet Neurol; 2022 Jun; 21(6):496-497. PubMed ID: 35525249
    [No Abstract]   [Full Text] [Related]  

  • 11. A practice game changer: Impact of tenecteplase for acute ischemic stroke in a multicenter quality improvement project.
    Noh L; Pham F; Haddad L; Burkhard T; Paletz L; Pech M; Lewis M; Manoukian V; Schlick KH; Song S
    Am J Health Syst Pharm; 2022 Apr; 79(9):e149-e153. PubMed ID: 35037028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenecteplase utility in acute ischemic stroke patients: A clinical review of current evidence.
    Nelson A; Kelly G; Byyny R; Dionne C; Preslaski C; Kaucher K
    Am J Emerg Med; 2019 Feb; 37(2):344-348. PubMed ID: 30471930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenecteplase for Acute Ischemic Stroke Treatment.
    Baird AE; Jackson R; Jin W
    Semin Neurol; 2021 Feb; 41(1):28-38. PubMed ID: 33472268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenecteplase use in patients with acute ischaemic stroke.
    Menon BK; Singh N; Sylaja PN
    Lancet; 2023 Feb; 401(10377):618-619. PubMed ID: 36774934
    [No Abstract]   [Full Text] [Related]  

  • 15. The promise of tenecteplase in acute stroke: Within reach or beyond approval?
    Zachrison KS; Schwamm LH
    Med; 2022 Oct; 3(10):651-655. PubMed ID: 36202099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: Tenecteplase for thrombolysis in stroke patients: Systematic review with meta-analysis.
    Bahadori M; Mowla A
    Am J Emerg Med; 2022 May; 55():185-186. PubMed ID: 34116894
    [No Abstract]   [Full Text] [Related]  

  • 17. Ethical Justification for Deferral of Consent in the AcT Trial for Acute Ischemic Stroke.
    Faris H; Dewar B; Dowlatshahi D; Ramji A; Kenney C; Page S; Buck B; Hill MD; Coutts SB; Almekhlafi M; Sajobi T; Singh N; Sehgal A; Swartz RH; Menon BK; Shamy M
    Stroke; 2022 Jul; 53(7):2420-2423. PubMed ID: 35603597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete recovery following intra-arterial tenecteplase administration in a woman with acute ischemic stroke.
    Meenakshi-Sundaram S; Periakaruppan A; Karuppiah SN; Karthik SN; Roopakumar L; Thembavani I
    J Clin Neurosci; 2013 Dec; 20(12):1786-8. PubMed ID: 23938013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenecteplase versus alteplase for acute ischemic stroke.
    González RG
    N Engl J Med; 2012 Jul; 367(3):275-6; author reply 276. PubMed ID: 22808969
    [No Abstract]   [Full Text] [Related]  

  • 20. Tenecteplase or Alteplase Better in Patients with Acute Ischemic Stroke Due to Large Vessel Occlusion: A Single Center Observational Study.
    Teivane A; Jurjāns K; Vētra J; Grigorjeva J; Kupcs K; Masiliūnas R; Miglāne E
    Medicina (Kaunas); 2022 Aug; 58(9):. PubMed ID: 36143846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.